Diagnostic evaluation of type 2 (classic) choroidal neovascularization: Optical coherence tomography, indocyanine green angiography, and fluorescein angiography

American Journal of Ophthalmology

Volumn 152, Issue 5, 2011, Pages

  Sulzbacher, Florian ^a   Kiss, Christopher ^a   Munk, Marion ^a   Deak, Gabor ^a   Sacu, Stefan ^a   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; FLUORESCENCE ANALYSIS; FLUORESCENCE ANGIOGRAPHY; HUMAN; IMAGE ANALYSIS; INDOCYANINE GREEN ANGIOGRAPHY; MALE; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHOTOGRAPHY; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINA EDEMA; RETINA MACULA AGE RELATED DEGENERATION; SLIT LAMP; SUBRETINAL NEOVASCULARIZATION; SUBRETINAL NEOVASCULARIZATION TYPE 2;

EID: 80054978052     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.04.011     Document Type: Article

References (20)

1. C.C. Klaver, R.C. Wolfs, and J.R. Vingerling Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study Arch Ophthalmol 116 5 1998 653 658 (Pubitemid 28414581)
2. K. Attebo, P. Mitchell, and W. Smith Visual acuity and the causes of visual loss in Australia Opthalmology 103 3 1996 357 364
3. J.P. Hoops, A. Schneider, and E.M. Messmer Choroidale Neovaskularisationen bei AMD; Korrelation histologischer und fluoreszenzangiographischer Befunde [in German] Ophthalmologe 95 5 1998 296 300 (Pubitemid 28265003)
4. H.E. Grossniklaus, and J.D.M. Gass Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes Am J Ophthalmol 126 1 1998 59 69 (Pubitemid 28341219)
5. F.K. Awad, J.S. Duker, and E. Reichel The digital indocyanine green videoangiography characteristics of well-defined choroidal neovascularization Ophthalmology 102 3 1995 401 405
6. U. Schmidt-Erfurth, R.A. Leitgeb, and S. Michels Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases Invest Ophthalmol Vis Sci 46 9 2005 3393 3402 (Pubitemid 44264330)
7. T. Wong, U. Chakravarthy, and R. Klein The natural history and prognosis of neovascular age-related macular degeneration Ophthalmology 115 9 2008 116 126
8. A.R. Shah, and L.V. Del Priore Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration Ophthalmology 116 10 2009 1901 1907
9. Macular Photocoagulation Study Group Subfoveal neovascular lesions in age related macular degeneration Guidelines for evaluation and treatment in the photocoagulation study Arch Ophthalmol 109 9 1991 1242 1257
10. F. Gelisken, W. Inhoffen, and U. Schneider Indocyanine green angiography in classic choroidal neovascularization Jpn J Ophthalmol 42 4 1998 300 303 (Pubitemid 28431805)
11. A. Obana, Y. Gohto, and M. Matsumoto Indocyanine green angiographic features prognostic of visual outcome in the natural course of patients with age related macular degeneration Br J Ophthalmol 83 4 2009 429 437
12. A.A. Chang, N.L. Kumar, and M.D. Zhu Indocyanine green localisation in surgically excised choroidal neovascular membrane in age-related macular degeneration Br J Ophthalmol 88 2 2004 307 309 (Pubitemid 38142113)
13. S.R. Sadda, S. Liakopoulos, and A.K. Pearse Relationship between angiographic and optical coherence tomographic (OCT) parameters for quantifying choroidal neovascular lesions Graefes Arch Clin Exp Ophthalmol 248 2 2010 175 184
14. W. Amoaku National Institute for Health and Clinical Excellence Ranibizumab: the clinician's guide to commencing, continuing and discontinuing treatment Eye 23 11 2009 2140 2142
15. A. Obana, Y. Gohto, and M. Matsumoto Indocyanine green angiographic features prognostic of visual outcome in the natural course of patients with age related macular degeneration Br J Ophthalmol 83 4 1999 429 437 (Pubitemid 29161184)
16. K.J. Blinder, S. Bradley, and N.M. Bressler Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1 Am J Ophthalmol 136 3 2003 407 418 (Pubitemid 37101236)
17. D.S. Beyer, A.N. Antoszyk, and C.C. Awh Subgroup analyses of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 2 2007 246 252 (Pubitemid 46172497)
18. S. Kang, and Y.J. Roh One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups Jpn J Ophthlmol 53 4 2009 389 395
19. D.M. Brown, M. Michels, and P.K. Kaiser Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study Ophthalmology 116 1 2009 57 65
20. P.K. Kaiser, D.M. Brown, and K. Zhang Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results Am J Ophthalmol 144 6 2007 850 857